Hydrate Inhibitors Market Research Research Report Information By Type (Thermodynamic Inhibitors (THIs), Low-Dosage Hydrate Inhibitors (LDHIs)) Application (Onshore Operations, Offshore Operations) Forecast 2030

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 23

1.1 MARKET ATTRACTIVENESS ANALYSIS 25

1.1.1 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE 26

1.1.2 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION 27

1.1.3 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION 28

2 MARKET INTRODUCTION 29

2.1 DEFINITION 29

2.2 SCOPE OF THE STUDY 29

2.3 MARKET STRUCTURE 30

3 RESEARCH METHODOLOGY 31

3.1 RESEARCH PROCESS 31

3.2 PRIMARY RESEARCH 32

3.3 SECONDARY RESEARCH 33

3.4 MARKET SIZE ESTIMATION 34

3.5 FORECAST MODEL 35

3.6 LIST OF ASSUMPTIONS 36

4 MARKET INSIGHTS 37

5 MARKET DYNAMICS 42

5.1 INTRODUCTION 42

5.2 DRIVERS 43

5.2.1 INCREASING DEMAND FOR LOW-DOSAGE HYDRATE INHIBITORS IN THE OIL & GAS INDUSTRY 43

5.2.2 ADVANCEMENTS IN THE DRILLING OF GAS HYDRATES 43

5.2.3 DRIVERS IMPACT ANALYSIS 44

5.3 RESTRAINTS 44

5.3.1 ENVIRONMENTAL ISSUES ASSOCIATED WITH THE USE OF ANTI-AGGLOMERATE (AA) LDHI 44

5.3.2 RESTRAINTS IMPACT ANALYSIS 45

5.4 OPPORTUNITIES 45

5.4.1 INCREASING INVESTMENTS IN OIL & GAS EXPLORATION ACTIVITIES IN DEVELOPING ECONOMIES 45

5.4.2 RESEARCH & DEVELOPMENT OF ECO-FRIENDLY HYDRATE INHIBITORS 46

5.5 CHALLENGES 47

5.5.1 REQUIREMENT OF HIGH DOSAGE OF THERMODYNAMIC INHIBITORS 47

5.5.2 AVAILABILITY OF DEPRESSURIZATION METHOD FOR CONTROLLING HYDRATE FORMATION 47

5.6 TRENDS 47

5.6.1 SHIFT TOWARD RENEWABLE SOURCES OF ENERGY 47

5.7 COVID 19 IMPACT ANALYSIS 48

5.7.1 ECONOMIC IMPACT ON THE OVERALL INDUSTRY 48

5.7.2 IMPACT ON PRODUCTION 48

5.7.3 IMPACT ON HYDRATE INHIBITORS INDUSTRY 48

5.7.4 IMPACT ON SUPPLY CHAIN 48

5.7.4.1 IMPACT ON RAW MATERIALS 49

5.7.4.2 PRICE VARIATIONS OF KEY RAW MATERIALS/COMPONENTS 49

5.7.4.3 CASH FLOW CONSTRAINTS 49

5.7.5 IMPACT ON PRICING 49

5.7.6 IMPACT ON WORLD TRADE 49

6 MARKET FACTOR ANALYSIS 50

6.1 SUPPLY CHAIN ANALYSIS 50

6.1.1 RAW MATERIALS SUPPLIERS 51

6.1.1.1 RAW MATERIAL SUPPLIERS FOR THERMODYNAMIC INHIBITORS (THIS) 51

6.1.1.2 RAW MATERIAL SUPPLIERS FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHIS) 51

6.1.2 HYDRATE INHIBITOR PRODUCERS 51

6.1.3 DISTRIBUTION CHANNEL 52

6.1.4 APPLICATIONS 52

6.2 PORTER’S FIVE FORCES MODEL 53

6.2.1 THREAT OF NEW ENTRANTS 53

6.2.2 THREAT OF SUBSTITUTES 54

6.2.3 BARGAINING POWER OF SUPPLIERS 54

6.2.4 BARGAINING POWER OF BUYERS 54

6.2.5 INTENSITY OF COMPETITIVE RIVALRY 54

6.3 PRICING ANALYSIS – BY REGION (USD/TON), 2021 55

6.4 GLOBAL MANUFACTURERS MARKET CONCENTRATION RATIO 55

7 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE 56

7.1 INTRODUCTION 56

7.2 THERMODYNAMIC INHIBITORS (THI) 58

7.3 LOW-DOSAGE HYDRATE INHIBITORS (LDHI) 60

8 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION 62

8.1 INTRODUCTION 62

8.2 OFFSHORE OPERATIONS 64

8.3 ONSHORE OPERATIONS 65

9 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION 66

9.1 OVERVIEW 66

9.2 NORTH AMERICA 70

9.2.1 US 74

9.2.2 CANADA 78

9.3 EUROPE 82

9.3.1 GERMANY 87

9.3.2 UK 91

9.3.3 FRANCE 95

9.3.4 ITALY 99

9.3.5 RUSSIA 103

9.3.6 NORWAY 107

9.3.7 NETHERLANDS 111

9.3.8 POLAND 115

9.3.9 DENMARK 119

9.3.10 REST OF EUROPE 123

9.4 ASIA-PACIFIC 127

9.4.1 CHINA 132

9.4.2 JAPAN 136

9.4.3 INDIA 140

9.4.4 AUSTRALIA & NEW ZEALAND 144

9.4.5 INDONESIA 148

9.4.6 SOUTH KOREA 152

9.4.7 THAILAND 156

9.4.8 REST OF ASIA-PACIFIC 160

9.5 LATIN AMERICA 164

9.5.1 BRAZIL 169

9.5.2 MEXICO 173

9.5.3 ARGENTINA 177

9.5.4 REST OF LATIN AMERICA 181

9.6 THE MIDDLE EAST AND AFRICA 185

9.6.1 GCC 190

9.6.2 NIGERIA 194

9.6.3 IRAN 198

9.6.4 IRAQ 202

9.6.5 EGYPT 206

9.6.6 REST OF THE MIDDLE EAST AND AFRICA 210

10 COMPETITIVE LANDSCAPE 214

10.1 COMPETITIVE OVERVIEW 214

10.2 GLOBAL MARKET STRATEGY ANALYSIS 214

10.3 COMPETITIVE BENCHMARKING 215

10.4 COMPETITION DASHBOARD 216

11 COMPANY PROFILES 217

11.1 SCHLUMBERGER 217

11.1.1 COMPANY OVERVIEW 217

11.1.2 FINANCIAL OVERVIEW 218

11.1.3 PRODUCT OFFERINGS 218

11.1.4 KEY DEVELOPMENTS 218

11.1.5 SWOT ANALYSIS 219

11.1.6 KEY STRATEGIES 219

11.2 BAKER HUGHES, A GE COMPANY LLC 220

11.2.1 COMPANY OVERVIEW 220

11.2.2 FINANCIAL OVERVIEW 221

11.2.3 PRODUCT OFFERINGS 221

11.2.4 KEY DEVELOPMENTS 222

11.2.5 SWOT ANALYSIS 222

11.2.6 KEY STRATEGIES 222

11.3 BASF SE 223

11.3.1 COMPANY OVERVIEW 223

11.3.2 FINANCIAL OVERVIEW 224

11.3.3 PRODUCT OFFERINGS 224

11.3.4 KEY DEVELOPMENTS 225

11.3.5 SWOT ANALYSIS 225

11.3.6 KEY STRATEGIES 225

11.4 HALLIBURTON 226

11.4.1 COMPANY OVERVIEW 226

11.4.2 FINANCIAL OVERVIEW 226

11.4.3 PRODUCT OFFERINGS 227

11.4.4 KEY DEVELOPMENTS 227

11.4.5 SWOT ANALYSIS 227

11.4.6 KEY STRATEGIES 227

12 COMPANY PROFILES 228

12.1 HUNTSMAN INTERNATIONAL LLC 228

12.1.1 COMPANY OVERVIEW 228

12.1.2 FINANCIAL OVERVIEW 229

12.1.3 PRODUCT OFFERINGS 229

12.1.4 KEY DEVELOPMENTS 230

12.1.5 SWOT ANALYSIS 230

12.1.6 KEY STRATEGIES 230

12.2 ASHLAND 231

12.2.1 COMPANY OVERVIEW 231

12.2.2 FINANCIAL OVERVIEW 232

12.2.3 PRODUCT OFFERINGS 232

12.2.4 KEY DEVELOPMENTS 233

12.2.5 SWOT ANALYSIS 233

12.2.6 KEY STRATEGIES 233

12.3 ARKEMA 234

12.3.1 COMPANY OVERVIEW 234

12.3.2 FINANCIAL OVERVIEW 235

12.3.3 PRODUCT OFFERINGS 235

12.3.4 KEY DEVELOPMENTS 236

12.3.5 SWOT ANALYSIS 236

12.3.6 KEY STRATEGIES 236

12.4 EVONIK INDUSTRIES AG 237

12.4.1 COMPANY OVERVIEW 237

12.4.2 FINANCIAL OVERVIEW 238

12.4.3 PRODUCT OFFERINGS 238

12.4.4 KEY DEVELOPMENTS 239

12.4.5 SWOT ANALYSIS 239

12.4.6 KEY STRATEGIES 239

12.5 HUNTSMAN INTERNATIONAL LLC 240

12.5.1 COMPANY OVERVIEW 240

12.5.2 FINANCIAL OVERVIEW 241

12.5.3 PRODUCT OFFERINGS 241

12.5.4 KEY DEVELOPMENTS 242

12.5.5 SWOT ANALYSIS 242

12.5.6 KEY STRATEGIES 242

12.6 ASHLAND 243

12.6.1 COMPANY OVERVIEW 243

12.6.2 FINANCIAL OVERVIEW 244

12.6.3 PRODUCT OFFERINGS 244

12.6.4 KEY DEVELOPMENTS 245

12.6.5 SWOT ANALYSIS 245

12.6.6 KEY STRATEGIES 245

12.7 ARKEMA 246

12.7.1 COMPANY OVERVIEW 246

12.7.2 FINANCIAL OVERVIEW 247

12.7.3 PRODUCT OFFERINGS 247

12.7.4 KEY DEVELOPMENTS 248

12.7.5 SWOT ANALYSIS 248

12.7.6 KEY STRATEGIES 248

12.8 EVONIK INDUSTRIES AG 249

12.8.1 COMPANY OVERVIEW 249

12.8.2 FINANCIAL OVERVIEW 250

12.8.3 PRODUCT OFFERINGS 250

12.8.4 KEY DEVELOPMENTS 251

12.8.5 SWOT ANALYSIS 251

12.8.6 KEY STRATEGIES 251

12.9 ECOLAB 252

12.9.1 COMPANY OVERVIEW 252

12.9.2 FINANCIAL OVERVIEW 253

12.9.3 PRODUCTS OFFERED 253

12.9.4 KEY DEVELOPMENTS 254

12.9.5 SWOT ANALYSIS 254

12.9.6 KEY STRATEGIES 254

12.10 FINORIC LLC 255

12.10.1 COMPANY OVERVIEW 255

12.10.2 FINANCIAL OVERVIEW 255

12.10.3 PRODUCTS OFFERED 255

12.10.4 KEY DEVELOPMENTS 255

12.10.5 SWOT ANALYSIS 256

12.10.6 KEY STRATEGIES 256

12.11 OMNI INDUSTRIAL SOLUTIONS 257

12.11.1 COMPANY OVERVIEW 257

12.11.2 FINANCIAL OVERVIEW 257

12.11.3 PRODUCTS OFFERED 257

12.11.4 KEY DEVELOPMENTS 257

12.11.5 SWOT ANALYSIS 258

12.11.6 KEY STRATEGIES 258

12.12 TETRA TECHNOLOGIES, INC. 259

12.12.1 COMPANY OVERVIEW 259

12.12.2 FINANCIAL OVERVIEW 260

12.12.3 PRODUCTS OFFERED 260

12.12.4 KEY DEVELOPMENTS 261

12.12.5 SWOT ANALYSIS 261

12.12.6 KEY STRATEGIES 261

13 APPENDIX 262

13.1 REFERENCES 262

13.2 RELATED REPORTS 263

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 36

TABLE 2 MANUFACTURERS MARKET CONCENTRATION RATIO, BY REGION 55

TABLE 3 GLOBAL HYDRATE INHIBITORS, BY TYPE, 2019–2030 (USD THOUSAND) 56

TABLE 4 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 57

TABLE 5 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 58

TABLE 6 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 58

TABLE 7 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY REGION, 2019–2030

(USD THOUSAND) 59

TABLE 8 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY REGION, 2019–2030 (TONS) 59

TABLE 9 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 60

TABLE 10 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 60

TABLE 11 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY REGION, 2019–2030

(USD THOUSAND) 61

TABLE 12 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY REGION, 2019–2030 (TONS) 61

TABLE 13 GLOBAL HYDRATE INHIBITORS, BY APPLICATION, 2019–2030 (USD THOUSAND) 62

TABLE 14 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 63

TABLE 15 GLOBAL HYDRATE INHIBITORS MARKET FOR OFFSHORE OPERATIONS, BY REGION, 2019–2030 (USD THOUSAND) 64

TABLE 16 GLOBAL HYDRATE INHIBITORS MARKET FOR OFFSHORE OPERATIONS, BY REGION, 2019–2030 (TONS) 64

TABLE 17 GLOBAL HYDRATE INHIBITORS MARKET FOR ONSHORE OPERATIONS, BY REGION, 2019–2030 (USD THOUSAND) 65

TABLE 18 GLOBAL HYDRATE INHIBITORS MARKET FOR ONSHORE OPERATIONS, BY REGION, 2019–2030 (TONS) 65

TABLE 19 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION, 2022-2030(USD THOUSAND) 67

TABLE 20 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION, 2022-2030(TONS) 68

TABLE 21 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2022-2030(USD THOUSAND) 69

TABLE 22 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2022-2030(TONS) 69

TABLE 23 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2022-2030(USD THOUSAND) 69

TABLE 24 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2022-2030(TONS) 69

TABLE 25 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 70

TABLE 26 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (TONS) 70

TABLE 27 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 70

TABLE 28 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 70

TABLE 29 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030

(USD THOUSAND) 71

TABLE 30 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 71

TABLE 31 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 72

TABLE 32 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(TONS) 72

TABLE 33 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 73

TABLE 34 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 73

TABLE 35 US HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 74

TABLE 36 US HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 74

TABLE 37 US HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 75

TABLE 38 US HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 75

TABLE 39 US HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 76

TABLE 40 US HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 76

TABLE 41 US HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 77

TABLE 42 US HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 77

TABLE 43 CANADA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 78

TABLE 44 CANADA HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 78

TABLE 45 CANADA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 79

TABLE 46 CANADA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (TONS) 79

TABLE 47 CANADA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030

(USD THOUSAND) 80

TABLE 48 CANADA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2019–2030 (TONS) 80

TABLE 49 CANADA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (USD THOUSAND) 81

TABLE 50 CANADA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2019–2030 (TONS) 81

TABLE 51 EUROPE HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (USD THOUSAND) 82

TABLE 52 EUROPE HYDRATE INHIBITORS MARKET, BY COUNTRY, 2019–2030 (TONS) 82

TABLE 53 EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (USD THOUSAND) 83

TABLE 54 EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2019–2030 (TONS) 83

TABLE 55 EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2019–2030 (USD THOUSAND) 84